on patient safety
and consumer justice.
Make sense of medical risks.
Keep current on preventative progress and patient safety strides.
Benjamin Duong · January 14, 2020
Heat is the culprit causing carcinogenic NDMA contamination in Zantac, according to recent testing by Emery Pharma. A citizen petition requesting a total suspension of ranitidine products has been submitted to the FDA.News
Carah Wertheimer · January 14, 2020
The end of Essure, a mysterious virus, a drop in U.S. cancer death rate and more news to begin 2020.News
Benjamin Duong · January 9, 2020
Insulin in the U.S. is costly, with a lack of generic insulin leaving diabetics with few options. The WHO is launching a pilot program to prequalify generic insulin products in hopes of increasing access to this vital drug.News
Carah Wertheimer · January 7, 2020
Controversial birth control Essure finally removed from the market, bringing celebratory remarks from the harmed patients who call themselves the "E-sisters."News
Carah Wertheimer · December 9, 2019
While recent reports reveal increased prevalence of measles deaths and prediabetes in adolescents, one recent study indicates a link between hair chemicals and risk of breast cancer. Meanwhile, Dr. Stephen Hahn has been recommended as the next FDA Commissioner after a 18-5 vote by the Senate Health, Education, Labor, and Pensions Committee. Here's last week in medical.News
Carah Wertheimer · November 25, 2019
While the U.S. observes urgent calls for bans on vaping products, the Sackler family catapults the opioid crisis abroad, with their affiliate company Mundipharma promoting OxyContin in China. Additionally, last week brought about several foodborne illness outbreaks, new findings on the rising prevalence of anal cancer, and a promising HIV vaccine discovery.News
Follow the stories.
Hear from real patients and explore evidence-based features.
NewsJanuary 7, 2020
By Carah Wertheimer
Controversial birth control Essure finally removed from the market, bringing celebratory remarks from the harmed patients who call themselves the "E-sisters."
Health FeaturesNovember 24, 2019
By Lauren Delisle
New York City's first-ever chronic illness convention, Chronicon, brought together patients and panelists living with chronic conditions — bringing light to a struggle that so many cope with but rarely discuss.
Health FeaturesOctober 24, 2019
By Lauren Delisle
Chronic illness affects six in 10 adults living in the United States -- a figure that is only expected to increase in coming years. Despite stigmas that stand in the way of societal treatment and comprehensive care methods, holistic and functional practitioners of medicine are working alongside patient advocates to make the world an easier place to live for those coping with chronic illness. Learn more about the movement to make invisible illnesses visible.
Health FeaturesSeptember 10, 2019
By Lauren Delisle
In January, 17-year-old Melody Saenz attempted suicide. Her experience with New York mental health services epitomizes the difficult journey to seeking mental health care, as pervasive stigmas, ill-equipped emergency departments and financial burdens add complex layers to finding treatment and recovery.
Laws + CongressJune 4, 2019
By Ashley Lombardo
In May, women from across the nation gathered at the United States Capitol to advocate for the Medical Device Safety Act. The bill, recently re-introduced in the House, aims to restore patients' Seventh Amendment rights. Here's why the women of the Medical Device Problems group are fighting for it.
Stay current on verdicts and settlements.
Dana Viola et al. v. Pfizer Inc.
The plaintiff has filed a complaint with Pfizer for marking Zantac as safe despite findings of NDMA in the product.
Linda O'Hagan et al. v. Johnson & Johnson et al.
Johnson & Johnson settled the case for an unknown amount after the FDA’s discovery of asbestos in their talcum product was shown in court.
Daniel Grove v. Adam Bowen et al.
JUUL Labs minority shareholders are filing suit with the executives and board members of JUUL Labs for improperly enriching themselves while causing significant financial damage to the stock value of JUUL Labs and unequally distributing profits to themselves before shareholders.
James Parker · January 7, 2020
Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.Legal Developments
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.Legal Developments
Nicole Knight · December 6, 2019
Six women have filed a complaint alleging the manufacturer Allergan intentionally hid possible breast implant safety risks.Legal Developments